Abstract
The need is now, but the solution takes over ten years. The race for speed is on, facilitated by billion-dollar fundraising and sustained investment in public-private partnerships. Accelerating COVID-19 vaccine development to “pandemic speed” has included many simultaneous projects, parallel clinical trials, fast-tracking experimental technology, and committing manufacturing capacity before regulatory approval.
| Original language | English |
|---|---|
| Publication date | 2020 |
| Publication status | Published - 2020 |
